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List of abbreviations 
Alk alkyl group 
Boc tert-butoxycarbonyl 
Cy cyclohexyl 
DCM dichloromethane 
DMAP 4-(dimethylamino)pyridine 
DMAS N,N-dimethylaminosulfamoyl 
DMF dimethylformamide 
DMPU N,N′-Dimethylpropylene urea 
EtOAc ethyl acetate 
EtOH ethanol 
MOM methoxymethyl ether 
NBS N-bromosuccinimide 
NMP N-Methyl-2-pyrrolidone 
BuLi butyl lithium 
TBAF tetrabutylammonium fluoride 
TBDMS tert-butyldimethylsilyl group 
THF tetrahydrofuran 
TMEDA tetramethylethylenediamine 
Ts tosyl group, that is, p-toluene sulfonyl 
TsN3 p-toluene sulfonyl azide 
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1 Introduction 
 For a long time natural products have been renowned for their drug-like properties and 
were used in treatment of various diseases and disorders.1 Thousands of bioactive compounds 
were isolated from a multitude of sources including both marine and terrestrial organisms. These 
chemical entities were further used as a starting point in the discovery and development of novel 
drugs for various therapeutic applications.2 It was estimated that 65% of today's approved drugs 
hold their origin in the chemistry of natural products.3 
 Alkaloids represent a huge class of natural compounds found in various marine and 
terrestrial life forms. Around sixty Leucetta and Clathrina-derived alkaloids that contain 2-
aminoimidazole moiety were isolated during last decades4. They include one or two benzylic 
substituents and in some cases there may be additional substitution on C-2 amino group, 
typically in a form of hydantoin moiety5 (Figure 1). 
 
Figure 1: Leucetta and Clathrina-derived alkaloids. 
 
 From the perspective of medicinal chemistry, these alkaloids exhibit versatile biological 
activity including cytotoxicity6, antibiotic activity7, nitric acid synthase inhibition8, leukotriene 
B4 antagonism9 and inhibition of epidermal growth factor (EFG) receptor activity.6a 
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 2 Literature review 
2.1 Naamidines as a class of alkaloids 
 Naamidines are a family of 2-aminoimidazole Leucetta-derived alkaloids including nine 
members5 (Figure 2) 
 
Figure 2: Alkaloids of naamidine family. 
 
 They show prominent biological activity. For instance, naamidine A was reported to 
exhibit antagonism towards the epidermal factor receptor and has been proven to be an active 
antitumor agent in vivo.10 Naamidine G demonstrated strong antifungal activity against 
phytopathogenic fungus Cladosporium herbarium11. Naamidines G, H and I have shown 
cytotoxicity against mouse limphoma (L5178Y) and human cervix carcinoma (HeLa) cells.10,11 
Biological activity of the naamidines requires in-depth study and synthetic methods must be 
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developed to provide sufficient amounts of the material. To date, of all the naamidines only 
naamidine A, G and H have been synthesized in a laboratory.5 
 
2.2 Synthetic pathways towards naamidines 
 Reviewing publications on the synthesis of naamidines, one can differentiate two 
approaches: construction of the imidazole ring via heterocyclization and elaboration of pre-
existing imidazole systems. 
 
2.2.1 Synthesis through heterocyclization  
 In 2006 Aberle et al.12 disclosed a sequence of six steps towards naamidine A that starts 
with a Boc-protected tyrosine derivative (Scheme 1). 
 
Scheme 1: Synthesis of naamidine A 
 
 The amino group was methylated with subsequent formation of a corresponding Weinreb 
amide. Further treatment with p-methoxybenzyl magnesium chloride provided the protected α-
aminoketone than was heterocyclized and deprotected by treatment with cyanamide followed by 
catalytic reduction. Finally, refluxing with TMS-derivatized parabanic acid in toluene furnished 
naamidine A in a yield of 80%. 
 
2.2.2 Synthesis on the ring of imidazole 
 This approach to the synthesis of naamidines is represented by three works.  
 The first one by Ohta and coworkers13 concerning naamidine A dates back to 2000 and 
includes 12 synthetic steps (Scheme 2). 
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Scheme 2: Synthesis of naamidine A. 
 
 N-methyl-2-phenylthioimidazole was lithiated at the 5-position of the imidazole ring and 
reacted with 4-(methoxymethoxy)benzaldehyde to produce the corresponding alcohol, which 
was then protected by tert-butyldimethylsilyl chloride. This intermediate was then brominated at 
the 4-position of imidazole ring with subsequent lithiation and treatment with p-
methoxybenzaldehyde. Two deprotection steps were then performed over the semi-protected 
diol: the silyl group was removed by means of TBAF followed by removal of the thiophenyl 
group at C2 by Ni(II)-catalyzed reduction. Another reduction step provided dibenzylated N-
methylimidazole in a yield of 44.9% (over 4 steps). It was bromiated again at C2 followed by 
lithiation with tert-BuLi and treatment with trisyl azide to provide 2-azidoimidazole. The azido 
group was reduced with hydrogen over Pd/C with subsequent deprotection with TBAF and 
condensation with N-methylparabanic acid to furnish naamidine A. The total yield over 12 steps 
was about 0.5%. 
 Naamidine G was synthetically accessed by Koswatta and Lovely14 in 2010. Their 
sequence includes eight steps (Scheme 3). 
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Scheme 3: Synthesis of naamidine A. 
 
 The key strategy was to perform sequential fictionalization of methylated 
diiodoimidazole: first C5, then C4 and finally C2 of the imidazole ring. Following this strategy, 
1-(dimethylsulfamoyl)-4,5-diiodoimidazole was metalated at the 5-position with 
ethylmagnesium bromide and then treated with p-methoxybenzaldehyde to furnish a 
corresponding alcohol which was reduced with triethylsilane in trifluoroacetic acid. The product 
was metalated again at C4 and treated with N-methylformanilide to form a corresponding 
aldehyde. The Grignard reaction with p-methoxyphenylmagnesium bromide was then conducted 
providing the alcohol. Again treatment with triethylsilane removed a hydroxyl group, affording 
corresponding 4,5-dibenzylated imidazole in a yield of 81%. Lithiation at the C2 of the 
imidazole ring by means of n-BuLi followed by treatment with tosyl azide furnished 2-
azidoimidazole which was catalytically reduced to a corresponding amine and then treated with a 
TMS-activated derivative of a parabanic acid. This afforded the target molecule naamidine G in 
8 steps with a total yield of 41%. 
 The third pathway towards one of the naamidines (naamidine H) was also described by 
Koswatta and Lovely15 in 2010 and includes only six steps (Scheme 4). 
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Scheme 4: Synthesis of naamidine H. 
 
 As in the previous case, the strategy of sequential fictionalization was applied. 1-
(Dimethylsulfamoyl)-4,5-diiodoimidazole was metalated with ethylmagnesium bromide with 
subsequent transmetalation by CuCN•2LiCl to afford a corresponding copper-species which was 
then coupled with p-methoxybenzyl bromide leading to N-protected 4-iodo-5-benzylimidazole. 
Another benzylic fragment was introduced in the same way to furnish 4,5-dibenzylated 
imidazole. To introduce the N-methyl group it was treated with methyl triflate and refluxed with 
benzylamine in acetonitrile which removed DMAS-protection. The hydantoin fragment was 
introduced into the molecule in the same way as in the previous sequence. The total yield of 
naamidine H was 20%. 
 All the attempts to use 1-methyl-4,5-diiodoimidazole as a starting point of the sequence 
on the Scheme 4 instead of 1-(dimethylsulfamoyl)-4,5-diiodoimidazole proved unsuccessful. 
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2.3 Kumada cross-coupling 
2.3.1 Definition and history  
 Kumada coupling is a type of cross-coupling reaction used to form carbon-carbon σ-
bonds. The process employs transition metal catalysis. Nucleophilic coupling partner is a 
Grignard reagent and electrophilic one can be organic halide or sulfonate (Scheme 5). 
R-MgX + R'-Y R-R'
cat.
R, R'=Alk, Ar, vinyl
Y=Halogen, OTs, OTf
 
Scheme 5: Kumada cross-coupling. 
 
 The process was firstly reported in 194116, however substantial yields were achieved only 
in 1972 by the groups of Robert Corriu17 and Makoto Kumada18 independently. Their reactions 
employed Ni-catalysis. Three years later the scope of the reaction was expanded by Pd-catalysis 
introduced by Murahashi group.19 As of today, in addition to common Ni and Pd, other metals 
such as Fe20, Mn21, Co22 and Cu23 are used to promote Kumada coupling. 
 
2.3.3 Advantages and restrictions  
 Kumada cross-coupling takes advantage of Grignard reagents being easily and cheaply 
available from commercial organohalides. Additionally, unlike in many other cross-coupling 
procedures, there is no need in further transmetallation steps to produce nucleophilic coupling 
partner, which makes this process highly atom-economical.24 Nevertheless, it has intrinsic 
disadvantage preconditioned by low functional group tolerance of organomagnesium halides. 
Alternative coupling procedures involving milder nucleophiles - organoboron, organozinc and 
organotin compounds25 circumvent this shortcoming yielding complex highly-functionalized 
molecules under rather mild conditions.  
 An important aspect of Kumada cross-coupling is the nature of solvent. The reaction is 
usually run in ethereal solvents which are used for the preparation of Grignard reagents and 
stabilize them by complexation.26 
 
2.3.2 Catalytic systems of interest 
 In 1971 Kochi proposed the use of iron salts to promote cross-coupling of organic halides 
and Grignard reagents.27 However, one year later Tamao-Kumada-Corriu coupling protocol 
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under Ni-catalysis was developed17,18 and iron was left unexplored for long years. Only little 
more than a decade ago the iron-assisted Kumada cross-coupling had its renaissance resulting in 
a multitude of fast and efficient coupling protocols.28  
 Iron catalyzed Kumada cross-coupling is more toxically and environmentally benign 
compared to its Pd- and Ni-counterparts. It is also cheap due to ample supply of iron28. 
Additionally, the reaction time can be as short as 5-10 min20b, which is significantly faster than 
alternative Ni and Pd protocols.29 As opposed to other catalysts for Kumada coupling, iron can 
operate at dry ice temperature. This fact broadens the scope of the reaction increasing 
regioselectivity as well as functional group tolerance30 since many Grignard reagents with 
electrophilic functionalities (e.g. -COOAlk, -CN, -NO2) are stable at low temperature47. All these 
advantages make iron an ideal industrial catalyst for synthesis of fine chemicals.15 
 Copper salts were reported to be active towards formation of diarylmethane systems 
which are a part of naamidine structure.23  
 
2.3.4 Mechanistic considerations  
 Catalytically active species in iron-catalyzed Kumada cross-coupling is a subject of 
controversy. Two main candidates are Fe(I) and Fe(-II). 
 First mechanistic research undertaken by Kochi et al. suggested Fe(I) based on by-
products profile.27 More recent computational study using density functional theory (DFT) also 
favors Fe(I) as a catalytic species.30 Lastly, ESR study of reduction of tris(dibenzoylmethido)iron 
(III) by Grignard reagent provides g-factor of 2.0832, which is compatible with data for other 
paramagnetic Fe(I) complexes.33 
 On the other hand, Fe(-II) has its own advocates. Bogdanović and Schwickardi reported 
of "inorganic Grignard", a highly reduced iron-magnesium cluster [Fe(MgX)2]n formed upon 
treatment of FeCl2 with alkylmagnesium halides in THF (Scheme 6).34a  
 
Scheme 6: Formation of "inorganic Grignard". 
 
 Additionally, reaction conducted with one of Fe(-II) complexes as a catalyst performed 
equally well as that using Fe(acac)3 and alkylmagnesium bromide.35c 
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 An important feature of iron-catalyzed Kumada cross-coupling is the lifetime of a 
catalytic species formed upon adding all reagents together. Mixing time should be kept as short 
as possible. Prolonged mixing results in poorer conversion27 which is due to deactivation of 
catalyst via oligomerization and further precipitation.30 The natural ways to prevent such a 
process would be dilution and ligation. For this reason the coupling is always run in ethereal 
solvents capable of stabilizing nascent iron species by complexation. Another way to stabilize 
the iron species is to keep it going through the catalytic cycle, therefore high concentration of a 
substrate prolongs lifetime of a catalyst.30 Small amounts of dipolar aprotic solvents (DMF, 
NMP, sulfolane etc.) also promote stabilization36 which was a reason of revitalized interest in 
this coupling more than a decade ago.28  
 Two mechanisms have been proposed for iron-catalyzed Kumada cross-coupling. 
 The most popular one is based upon findings of Kumada and Corriu for Ni-catalyzed 
reaction17,18 and involves oxidative addition (OA), transmetallation (TM) and reductive 
elimination (RM). It is unclear whether OA or TM comes first, therefore both pathways must be 
taken into account (Scheme 7). 
 
Scheme 7: Classical mechanism for iron-catalyzed Kumada cross-coupling. Ligands are 
excluded. R, R'=Csp2, Csp3. Steps in a catalytic cycle: a - transmetallation, b - oxidative addition, 
c - reductive elimination. 
 
 Recent theoretical study by Kleimark et al. indicates that in Fe(I)/Fe(III) catalytic cycles 
there is little to differentiate between the two pathways from a kinetic point of view.30 
 There is ample experimental evidence of radical involvement35c,20 which is not 
compatible with the classical mechanism on the Scheme 7. For that reason another catalytical 
cycle was proposed that includes a single electron transfer (SET) step (Scheme 8).20b  
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Scheme 8: Coupling via SET-pathway. Ligands are excluded. R, R'=Csp2, Csp3. Steps in a 
catalytic cycle: a - radical oxidative addition, b - transmetallation, c - recombination, d - 
reductive elimination. 
 
 Scheiper et al.37 suggested that the reaction may follow different pathways. In their 
opinion the mechanism is determined by the nature of Grignard nucleophile. The authors 
analyzed stochiometry of the cross-coupling with different alkylmagnesium halides and 
concluded that, unless nucleophiles with β-H atoms are used, they are not consumed for the 
reduction of iron (Scheme 6) and instead a ferrate complex is formed which promotes the 
reaction. Otherwise highly reduced [Fe(MgX)2]n clusters are produced.  
 The mechanistic details of copper-catalyzed Kumada cross-coupling are more clear than 
those for iron. The mechanism was studied by Tamura and Kochi and involves Cu(I) catalytic 
species (Scheme 9).38 
RMgX
CuIX
R-CuI
MgX2R'X
R-R'
ab
 
Scheme 9: The mechanism of Cu-catalyzed Kumada coupling. Steps in a catalytic cycle: a - 
transmetallation, b - metathesis. 
 
 Both Cu(I) and Cu(II) salts can be used as the pre-catalyst.39 The reaction allows all 
combinations of sp2 and sp3 nucleophiles and electrophiles, including aryl-aryl.40 
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2.3.5 Diarylmethanes via Kumada coupling  
 The structure of naamidine B includes two diarylmethane fragments (Figure 1). 
 There is only one known example of iron-catalyzed Kumada cross-coupling leading to 
diarylmethanes.41 The authors coupled arylmagnesium bromides with benzyl halides using a 
complex of Fe(III) with amine-bis(phenol) ligand (Scheme 10). 
Scheme 10: Coupling to diarylmethanes. 
 
 All other attempts to synthesize diarylmethanes by means of iron-catalyzed Kumada 
cross-coupling proved unsuccessful. Supposedly, due to inherent instability and fast aggregation 
of  nascent iron species.40c 
 Diarylmethanes can also be produced using Cu-catalysis which was demonstrated by 
Dohle et al. (Scheme 11).39 
 
Scheme 11: Diarylmethanes via Cu-catalysis. 
 
 Koswatta and Lovely applied Cu-catalysis for their total synthesis of naamidine G and 
naamidine H (Scheme 12).15 
 
Scheme 12: Cu-catalysis in total synthesis of naamidines. 
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3 Aim of the project 
 The primary aim of the project was an investigation of the synthetic steps towards 
naamidine B. As a strategic approach, we chose elaboration of the pre-existing imidazole core 
rather than de novo construction of the heterocycle. This strategy not only permits the synthesis 
of the target molecule, but also facilitates the development of new imidazole chemistry. 
 To approach the key intermediate A (Scheme 13) we had to develop a flexible and robust 
methodology towards benzylation of the imidazole core.  
Naamidine B
N
N X
DMAS
I
MgY
R
+
N
N
OMe
HO
MeO
DMAS
N
N X
DMAS
MgBr
Y
R
+
N
N
OMe
HO
MeO
Me
N
H
N
N
O
O
Me
Y
R
N
N
H X
I
N
N X
DMAS
I
N
N
H X
I
key intermediate
A
B
B
C
D E
E
F
F
 
Scheme 13: Retrosynthetic analysis of naamidine B structure. X=I, H; Y=Cl, Br, I. 
 
 Kumada cross-coupling is known to provide benzylation of the aromatic systems15,39,41, 
however the literature data on it are very incomplete and fragmentary. This coupling protocol 
performs with different metals as a catalyst. Iron-catalyzed Kumada benzylation was 
successfully performed by only one research group41, meanwhile the use iron has numerous 
advantages over other metals. It is more toxically and environmentally benign compared to its 
Pd- and Ni-counterparts. It is also cheap due to the ample supply.28 Additionally, the reaction 
time can be as short as 5-10 min20b, which is significantly faster than alternative Ni and Pd 
protocols.29 As opposed to other catalysts for Kumada coupling, iron can operate at dry ice 
temperature. This fact broadens the scope of the reaction increasing regioselectivity as well as 
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functional group tolerance30 since many Grignard reagents with electrophilic functionalities (e.g. 
-COOAlk, -CN, -NO2) are stable at low temperature.47 All these advantages make iron an ideal 
industrial catalyst for synthesis of fine chemicals.15 
 The key intermediate A contains two diarylmethane fragments and can be synthesized 
either by coupling aryliodide B with benzylgrignard C, or arylgrignard D with benzylhalide E 
(Scheme 13). 
 The procedure for copper-catalyzed Kumada coupling leading to diarylmethanes was 
previously described in the literature.15 Our aim was to modify this procedure to be able to 
perform one-pot bis-benzylation of B (X=I) with C. This way one can save synthetic steps which 
should increase the total yield of the target naamidine B. 
 Another aim was to develop an iron-catalyzed Kumada coupling procedure leading to 
diarylmethanes. There is only one example of such coupling in the literature41, but it requires 
complex ligands and was never tested for heterocycles.  
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4 Discussion and results 
4.1 Synthesis of starting materials 
4.1.1 Synthesis of 1, 2, 4 and 5 
 4,5-Diiodo-1H-imidazole (1)42 . Solution of I2 in KI was slowly added to imidazole 
dissolved in 4.0 M NaOH. The reaction mixture was stirred at room temperature for 24 h to 
afford 1 in 82% yield (Scheme 14).  
 
Scheme 14: Iodination of imidazole. 
 
 4-(5)-Iodo-1H-imidazole (2)43. A suspension of 4,5-diiodo-1H-imidazole (1) and K2SO3 
was refluxed in 30% EtOH for 24 h to furnish the title compound as white crystals in a yield of 
65% (Scheme 15). 
 
Scheme 15: Synthesis of 4-(5)-Iodo-1H-imidazole. 
 
 1-(Dimethylsulfamoyl)-4-iodoimidazole (4). An attempt to derivatize 4-(5)-iodo-1H-
imidazole (2) with N,N-dimethylsulfamoyl chloride in the presence of NEt3 proved unsuccessful. 
Conversion of 2 was incomplete and a mixture of two isomers 3 and 4 formed (according to GC-
MS). To accelerate the reaction we used a stronger base (50% aqueous NaOH) in accordance 
with the procedure by Bhagavatula et al. (Scheme 16).44 
THF
r.t., 24 h
N
N
H
I
+ DMASCl
N
N
I
DMAS
N
N
DMAS
I
(1.00 equiv) (1.05 equiv)
+
50% aq. NaOH
3 42
 
Scheme 16: Protection 4-(5)-Iodo-1H-imidazole. 
 
 It resulted into complete conversion of 2 but also a mixture of isomers. An excessive 
amount of DMASCl (0.05 eq.) was used for the next step of the procedure where 3 was 
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converted into 4 while stirring in heptane at 70 oC. In this case DMASCl performs as a catalyst 
forming a bis-DMAS salt which is unstable and due to sterical strain decomposes to form the 
less hindered isomer 4 (Scheme 17). 
 
Scheme 17: Isomerization step. 
 
 Another factor promoting the process is that of the two isomers 4 is less soluble in 
heptane. 
 The aforementioned procedure provided 1-(dimethylsulfamoyl)-4-iodoimidazole with 
>99% purity (1H NMR) in a yield of 91%.  
 
 1-(Dimethylsulfamoyl)-4,5-diiodoimidazole (5). 4,5-Diiodo-1H-imidazole (1) was 
converted into the title compound using DMASCl in the presence of NaOH (Scheme 18).  
 
Scheme 18: Protection of diiodoimidazole. 
 
 The main challenge in this synthesis was poor solubility of 4,5-diiodo-1H-imidazole (1) 
in THF, even with 1.5 equiv of 50% NaOH. Acetone was a good solvent, however no conversion 
took place in it. We have discovered that slight dilution of the reaction mixture in THF with 
water makes 1 completely dissolve. This procedure provided 1-(dimethylsulfamoyl)-4,5-
diiodoimidazole (5) in a yield of 78%.  
 
4.1.2 1-(Dimethylsulfamoyl)-4-chloroimidazole (6) 
 We needed to access 1-(dimethylsulfamoyl)-4-chloroimidazole for the scope of the iron-
catalyzed Kumada cross-coupling. No synthetic ways were described in the literature affording 
this molecule. The strategy we previously applied for 1-(dimethylsulfamoyl)-4-iodoimidazole 
was not expected to work. We considered that the first step would also result in a mixture of 
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isomers similar to 3 and 4. However, the isomerization step would fail due to less sterical 
hindrance caused by the chlorine compared to the iodine. 
 Instead, we attempted to perform aromatic halogen exchange on 4 which would afford an 
easier access to the title compound 6 (Scheme 19). 
 
Scheme 19: Attempts towards 1-(dimethylsulfamoyl)-4-chloroimidazole (6). 
 
 We tried to exchange I for Cl similarly to a halex reaction45 using an excess of KCl in 
DMF at 160 oC. As a result, neither the starting material nor the product were detected in a crude 
(GC-MS). 
 Another attempt using anhydrous CuCl in anhydrous and degassed pyridine46 was 
successful and provided 1-(dimethylsulfamoyl)-4-chloroimidazole in a yield of 74%.  
 
4.1.3 Synthesis of organomagnesium halides 
 Arylmagnesium bromides. 1-(Dimethylsulfamoyl)-4-imidazolylmagnesium bromide 
and other arylmagnesium bromides were produced from the corresponding aryl iodides via an 
exchange reaction with EtMgBr47 in THF at 0 oC (Scheme 19).  
 
Scheme 19: Exchange with ethylmagnesium bromide and quenching. 
 
 The reaction was monitored by taking aliquotes, quenching them with saturated aqueous 
NH4Cl and analyzing with GC-MS. With 1-(dimethylsulfamoyl)-4-iodoimidazole (4) an 
exchange was complete within 5 min, iodobenzene and 2-iodoanisole were left to react for 2 h. 
 1-(Dimethylsulfamoyl)-4-imidazolylmagnesium bromide 7 has rather low solubility in 
THF at 0 oC and forms a suspension. The use of Et2O as a solvent did not prevent precipitation. 
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 Benzylmagnesium halides. We could not produce p-methoxybenzyl bromide by 
exchange reaction with EtMgBr47. The yield at 0 oC was extremely low, at -20 oC only cross- and 
homocoupling by-products 11 and 12 were forming (Scheme 20). 
 
Scheme 20: Benzylgrignard via an exchange reaction. 
 
 The reaction was monitored in the same way as in the synthesis of arylmagnesium 
bromides. 
 Another way to synthesize 10 we tried was sonication of 9 with magnesium turnings at 30 
oC (Scheme 21). 
 
Scheme 21: Benzylgrignard via sonication with Mg turnings. 
 
 The only by-product in this case was the homocoupling 12. Concentration of the resulting 
p-methoxybenzyl bromide 10 solution was determined by titration with I2 in 0.5 M LiCl in THF. 
It corresponded to the yield of 23% and did not change when sonication time was increased from 
5 to 15 min. 
 The same procedure applied to benzyl chloride provided the corresponding 
organomagnesium chloride in a yield of 40%. 
 
4.2 Kumada coupling with copper 
 The molecule of Naamidine B contains two diarylmethane fragments (Figure 1). 
Diarylmethanes can be produced by coupling aryl Grignard reagents with benzyl bromides using 
Cu-catalysis (Scheme 11).39 
 It is also known from the literature that aryl bromides and iodides easily undergo 
Grignard exchange with Csp3 magnesium halides (Scheme 22).48 
 
Scheme 22: Grignard exchange. X=Br, I. Y=Cl, Br, I. 
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 Our assumption was that the aforementioned coupling procedure may be inverted, and 
aryl iodide with benzyl magnesium halide may be used instead. If so, this approach may be 
employed to develop a procedure for one-pot bis-benzyl substitution in imidazole ring leading to 
a structural fragment of naamidines (Scheme 23). 
 
Scheme 23: One-pot bis-benzyl substitution in imidazole ring. 
 
 Since C-5 in 1-(dimethylsulfamoyl)-4,5-diiodoimidazole 5 is more electron-deficient than 
C-4, we expected C-5 to be the initial exchange and coupling site. 
 Our first step was to determine if the inverted approach works. As a model reaction we 
chose the coupling between 1-(dimethylsulfamoyl)-4-iodoimidazole (4) and benzyl magnesium 
chloride (Scheme 24). 
 
Scheme 24: Model reaction for the inverted coupling approach with the detected side-products. 
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 Considering that the lower temperature increases stability of Grignard reagents with 
electrophilic functionalities47, thus broadening the scope of the reaction, we tried the reaction at 
different temperatures. In addition to the expected product, we also observed homocoupling of 
both coupling partners 17 and 18 and some amount of the unreacted 1-(dimethylsulfamoyl)-4-
imidazolylmagnesium chloride (14) which was transformed into 1-(dimethylsulfamoyl)imidazole 
(8) during the work-up with saturated aqueous NH4Cl (Scheme 24). The results are presented in 
the Table 1.  
Table 1: Coupling at different temperatures. 
Entry Temperature [oC] 
Yield [%]d 
16 8 17 
1 -63 traces 99 traces 
2 -41 4 96 traces 
3 -23 65 (58)c 35 traces 
4b -23 46 11 43 
aTo a solution of 4 (0.166 mmol, 1 eq.) and CuCN•2LiCl (0.033 mmol, 0.2 eq., 1 M in THF) in 
THF (3.0 ml) benzyl magnesium chloride was added (0.200 mmol, 1.2 eq., 0.3 M in THF). The 
reaction was left at low temperature for 6 h and the allowed to warm up to room temperature 
overnight. b Solution of CuCN•2LiCl used for the reaction was contaminated with solid particles 
of CuO. c Isolated yield in parenthesis. dAccording to GC-MS. 
 
 From the Table 1, the reaction only proceeds when the temperature is kept at -23 oC 
(Entry 3). At lower temperature (Entries 1 and 2) ample precipitation of 1-(dimethylsulfamoyl)-
4-imidazolylmagnesium chloride (14) was observed and the coupling was too slow. It is also 
notable that reactions kept at low temperature for too long did not proceed upon heating up, 
which may indicate limited lifetime of a catalytic species. 
 One of the experiments at -23 oC (Entry 4) showed anomalously increased amount of 
imidazole homocoupling 17. It was run with freshly prepared solution of a catalyst (1M 
CuCN•2LiCl in THF) containing suspended particles of CuO as a contaminant. We assume that 
it may promote Ullmann-type homocoupling to the biaryl 17 (Scheme 25). 
 
Scheme 25: Homocoupling in the presence of CuO. 
  
 After finding conditions for the inverted procedure we proceeded to the bis-substitution 
on imidazole ring (Scheme 26). 
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Scheme 26: Attempted bis-benzylation. 
 
 However, the reaction stopped at the Grignard exchange and the actual cross-coupling did 
not proceed. Instead of the cross-coupling product 20, after the work-up with saturated aqueous 
NH4Cl only 4 was detected in GC-MS. 
 The organic magnesium halides are known to be especially stable in ethereal solvents due 
to strong complexation of solvent oxygen atoms with magnesium centers26. Therefore, to make 
19 more reactive we tried to replace THF with DCM which is incapable of such complexation. 
Lovely et al. applied the same principle in their synthesis of imidazole-based marine alkaloids.15 
However, it is impossible to replace all the THF in the reaction, as both benzyl magnesium 
chloride and CuCN•2LiCl solutions are prepared in this solvent. Instead, we tried to run the 
reaction in DCM/THF, 80:20. Nevertheless, it resulted only in the Grignard exchange as in the 
previous case. 
 
4.3 Kumada coupling with iron 
 There are two ways to assemble a diarylmethane fragment in naamidines. For brevity we 
called them the direct and inverse coupling (Scheme 27). 
 
Scheme 27: Direct (a) and inverse (b) coupling. X=Cl, Br, I. 
 
 The direct coupling (a) implies the use of aryl magnesium halide A as a nucleophilic 
coupling partner, meanwhile the inverse procedure (b) utilizes benzyl magnesium halide B. 
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4.3.1 Direct coupling  
 We tested the direct approach with the protected 4-imidazolyl Grignard reagent 21 and p-
methoxybenzyl bromide 9 (Scheme 28). Bromide was chosen over chloride due to the weaker 
bond between benzylic carbon and halogen. 
 
Scheme 28: Direct coupling. 
 
 Different sets of conditions and additives were tested (Table 2) to promote the reaction 
towards the desired cross-coupling product 22. However, in all the cases after quenching with 
saturated aqueous NH4Cl we observed several side products 8, 12, 17. 
Table 2: Direct coupling. 
Entry Additive Yield [%]
h
 
22 8 17 
1c - traces >99 traces 
2 - 18 39 43 
3d - 2 20 78 
4e - 6 26 67 
5 DMPUf 35 53 12 
6 NMPf 28 67 5 
7 Sulfolanef 10 63 26 
8 TMEDAg 5 85 10 
aFe(acac)3 (0.0117 g, 0.03 mmol, 10 mol%) was dissolved in anhydrous THF (2.0 ml) and then 
p-methoxybenzyl bromide (48 µl, 0.33 mmol) added. The vial was placed into an ice bath and 
suspension of 1-(dimethylsulfamoyl)-4-imidazolylmagnesium bromide (0.33 mmol in 2.0 ml 
THF) was added and reaction mixture was stirred at r.t. for 1 h. bAll the reactions were complete 
very fast (within 10-20 min) and GC-MS showed no changes in the next 24 h. cNo catalyst 
added. dReaction at 30 oC. eGrignard reagent added over 0.5 h. f9 equiv. g1 equiv. hAccording to 
GC-MS. 
 
 The color change is notable for all the reactions. The orange solution containing 
Fe(acac)3 immediately turns green once the Grignard reagent is added and it remains so until 
exposed to air which results in a slow change of coloration to yellow. 
 As can be seen from the Table 2, virtually no reaction takes place unless Fe(acac)3 is 
present (Entry 1). Conditions typically applied for Fe-catalyzed Kumada cross-coupling with 
other substrates49 proved ineffective for us - extensive homocoupling 17 was observed instead 
and more than a third of the starting arylmagnesium bromide remained unreacted (Entry 2). 
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Increased temperature provided even more homocoupling 17 destabilizing the iron catalytic 
species (Entry 3). We tried to apply kinetic control and create a limited concentration of the 
arylgrignard reagent 21 in the reaction mixture injecting its solution slowly over 0.5 h (Entry 4). 
The assumption was that it would promote the cross-coupling and decrease the chances of two 
arylgrignard molecules meet one another and homocouple. However, it resulted in even worse 
yield of 22 than in case of fast injection. We considered the decreased yield a consequence short 
catalyst lifetime28,30, therefore different additives capable of complexation with the catalytic 
species50 were tested (Entries 5-8). They indeed decreased the yield of homocoupling 17 and 
some even improved that of the desired product 22 (Entries 5, 6), however all of them resulted in 
a higher yield if the by-product 8. 
 Another problem of the direct coupling was low solubility of the arylgrignard reagent 21 
in THF at 0 oC (less than 46 mg/ml), therefore reactions had to be run at big dilution (see the 
procedure), but even then it precipitated again if the temperature was decreased to -10 oC. This 
fact discouraged us from trying the direct approach at low temperatures. From our observations, 
replacement of THF with ether does not improve solubility much. 
 
4.3.2 Inverse coupling 
 In parallel to the experiments with the direct approach we were trying to perform the 
cross-coupling using benzylmagnesium chloride (13) and 1-(dimethylsulfamoyl)-4-
iodoimidazole (4) (Scheme 29). 
 
Scheme 29: Inverse Kumada coupling. 
 
 In this case we also observed a broad spectrum on by-products one of which was benzyl 
iodide (15) not detected in the experiments with the direct coupling. The most likely source of it 
is an exchange reaction between 4 and 13. 
 As with the direct coupling, here we also varied different reaction parameters and 
additives to promote the reaction towards the desired cross-coupling product 16 (Table 3). 
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Table 3: Inverse coupling. 
Entry Additive Reaction volume [ml] 
Temperature 
[oC] 
Yield [%]k 
16 8 4 17 
1b - 4.4 0 0 >99 0 traces 
2 - 4.4 0 6 17 5 72 
3c - 4.6 0 5 17 1 77 
4 CuCN•2LiClg 4.7 0 1 19 0 80 
5d CuCN•2LiClg 4.7 60 0 35 1 64 
6 Sulfolaneh 4.6 0 10 11 17 62 
7 TMEDAg 4.6 0 4 7 29 60 
8 PPh3i 4.6 0 9 36 5 50 
9 PPh3j 4.6 0 7 31 5 57 
10 PPh3i 1.1 0 24 23 15 37 
11 (Ph2PCH2)2i 1.1 0 0 26 31 42 
12e PPh3i 1.1 -41 36 23 13 28 
13f PPh3i 1.1 -84 57 40 2 1 
aTo a solution of 1-(dimethylsulfamoyl)-4-iodoimidazole (0.050 g, 0.166 mmol), Fe(acac)3 
(0.006 g, 0.017 mmol, 10 mol%) and an additive in THF at low temperature benzylmagnesium 
chloride solution (0.3 M in THF, 0.68 ml, 0.200 mmol) was added. Reaction was complete 
within one hour (GC-MS). bNo catalyst used. cSimultaneous addition of catalyst (in 1.83 ml of 
THF) and benzylmagnesium chloride solutions. dReaction time 24 h. eReaction was kept at -41 
oC for 1 h and then was allowed to warm up to rt. fReaction was kept at -84 oC for 3.5 h and then 
was allowed to warm up to rt. g1 equiv. h9 equiv. i20 mol%. j8 x 20 mol%. kAccording to GC-
MS. 
 
 As with the direct procedure, no coupling is possible unless the catalyst is present in the 
reaction (Entry 1). Instead, the Grignard exchange takes place leading to arylmagnesium chloride 
14 which is converted into 1-(dimethylsulfamoyl)imidazole (8) upon quenching with saturated 
aqueous NH4Cl (Scheme 30). 
 
Scheme 30: Grignard exchange. 
 
 Conditions normally applied for iron-catalyzed Kumada cross-coupling with other 
substrates49 proved unproductive in our case - most of the starting material 4 remained unreacted 
(Entry 2). We associated this with short lifetime of a catalytically active species formed upon 
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reduction of Fe(III) with the benzylgrignard reagent, which is also known from the literature.27,51 
One proposal was to keep little yet stable concentration of the species by slow simultaneous 
addition of Fe(acac)3 and benzylmagnesium chloride solutions to the starting iodide 4 in THF 
(Entry 3). However it did not provide any improvement as, we think, active concentration of a 
catalyst was too low to promote the reaction effectively. The presence of copper is known to 
produce synergetic effect and stabilize the catalytically active species40c, nevertheless for us it 
only resulted into increased amounts of homocoupling 17 (Entries 4, 5). Another way for 
stabilization may be ligation with dipolar aprotic solvents50a, nitrogen-50b or phosphorus-
containing ligands. However, none of them provided any significant improvement (Entries 6-9). 
We assumed that complexation may be enhanced in more concentrated reactions. Additionally, 
aggregation of a catalyst may be suppressed due to higher probability to meet another substrate 
molecule and start a new catalytic cycle30. This approach provided the increased yield with PPh3 
(Entry 10), however the cross-coupling did not proceed with the bidentate (Ph2PCH2)2 (Entry 11) 
which, we think, binds to the catalytic species too strongly leaving no reactive sites. Reduced 
temperature resulted in even higher yield prolonging the lifetime of a catalyst (Entries 12, 13). 
 It is worth pointing out that the reaction is always accompanied by the color change. 
Slightly orange solution containing Fe(acac)3 turns dark bloody red once benzylmagnesium 
chloride (13) solution is added. The coloration persists for longer time at lower temperature and, 
according to GC-MS, it is when the cross-coupling product 16 is being formed. In a while, or 
almost instantaneously if heated up to room temperature, the coloration changes again to brown 
(or blue with PPh3) and the reaction stops. The final change to yellow takes place over several 
minutes when the reaction is exposed to air. 
 Referring to the Table 3, the yield of the cross-coupling 16 depends on reaction time and 
temperature (Entries 12, 13). To find optimal conditions we ran the reaction at three different 
temperatures (-84, -63 and -41 oC). The results are presented in the Table 4 and Figure 3. 
Table 4: Cross-coupling at different temperatures. 
Time  
[h] 
Temperature 
[oC] 
Yield [%]c 
16 8 4 17 
3 
-41 60 32 8 0 
-63 46 49 5 0 
-84 23 72 6 0 
6 
-41 61 31 8 0 
-63 67 30 4 0 
-84 25 69 6 0 
Overnightb 
-41 67 25 8 0 
-63 80 17 3 0 
-84 60 32 6 2 
aTo a solution of 1-(dimethylsulfamoyl)-4-iodoimidazole (0.050 g, 0.166 mmol), Fe(acac)3 
(0.006 g, 0.017 mmol, 10 mol%) and an PPh3 (0.009 g, 0.033 mmol) in THF (0.5 ml) at low 
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temperature benzylmagnesium chloride solution (0.3 M in THF, 0.68 ml, 0.200 mmol) was 
added. bAfter 6 h reaction was left in a cooling bath overnight to warm up to room temperature. 
cAccording to GC-MS. 
 
 
Figure 3: Cross-coupling at different temperatures. 
 
 The data we obtained give a good insight into how the reaction is proceeding. In the 
Figure 3 there are three pairs of lines for the experiments monitored at different temperature. It is 
notable that at every temperature the lines corresponding to the cross-coupling 16 and 1-
(dimethylsulfamoyl)imidazole (8) are almost symmetrical to one another and after 3 h the yield 
of 8 is decreasing over time. This testifies the exchange (Scheme 30) taking place first and 
preceding the actual cross-coupling. It is also evident that there is a certain temperature window 
centered at around -63 oC where the cross-coupling gives the optimal yield. At higher 
temperature (-41 oC) the reaction runs faster, however the catalytic species almost looses its 
activity within first 3 hours, which is also accompanied by the change in coloration. At -84 oC 
limited solubility of 1-(dimethylsulfamoyl)-4-imidazolylmagnesium chloride 14 comes to the 
fore. Once it forms, a great fraction of it precipitates and the rest is consumed for the cross-
coupling, but then the solid redissolves too slowly to provide any significant increase in a yield 
of 16. The catalytically active species lives for quite long at -84 oC and when the reaction is 
allowed to heat up to room temperature, the solubility of 14 increases and the yield grows 
dramatically by 35%. There was enough starting material 14 for a better yield, however, most 
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likely, at some point the temperature reached the limit where the catalytic Fe-species became 
unstable and formed homocoupling 17 (Table 4). 
 Even though the best result we got was 80% (Table 4), we were interested in the 
opportunities for further optimization. For that we had to find out the source of the remaining 1-
(dimethylsulfamoyl)imidazole (8). It is known from the literature that the highly reduced Fe-
species formed in the course of the reaction is capable of single electron transfer (SET) opening 
undesired radical manifolds.20b,52 Based on that, before the exchange takes place (Scheme 31) 
starting iodide 4 may capture an electron from the Fe-species, become an radical-anion, fragment 
to a radical and abstract a hydrogen atom from the environment. We assume that it may be the 
solvent (Scheme 31). 
 
Scheme 31: Proposed catalytic reduction via a SET-step. 
 
 To check whether such a reduction takes place, we took two aliquots from the completed 
reaction and quenched them with H2O and D2O. If 1-(dimethylsulfamoyl)imidazole (8) 
originates from arylgrignard 14, then after D2O quench the mass spectrum should show the 
increased intensity of [M+1] peak (Scheme 32) compared to that after H2O quench.  
 
Scheme 32: D2O quench of the arylgrignard 14. 
 
 The data we obtained are presented in a Figure 4. 
 
 32
 
 
 
(a) (b) 
Figure 4: Isotopic distribution of 1-(dimethylsulfamoyl)imidazole (8) after H2O (a) and D2O (b) 
quench (according to GC-MS). m/z ([M])=175; m/z ([M+1])=176.2.  
 
 In a Figure 4 the two spectra represent isotopic distribution after the aliquote from the 
reaction was quenched with H2O (a) and D2O (b). Even though the heavy water quench shows 
increased abundance of [M+1] species, [M] remains the predominant one which indicates that 
most of the remaining 1-(dimethylsulfamoyl)imidazole (8) originates from the catalytic 
reduction, probably via a SET-step (Scheme 31). However, the Grignard reagent 14 is not fully 
consumed and the yield of the reaction still may be optimized by prolonging the reaction time. 
This analysis had to be done with GC-HRMS, however due to technical problems we had only 
GC-MS in our disposal. 
 Based on these conclusions, now it is possible to draw the reaction scheme with all the 
side-reactions we observed (Scheme 33). 
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Scheme 33: Inverse Kumada coupling and the side-reactions. a - Grignard exchange, b - cross-
coupling, c - homocoupling, d - catalytic reduction, e - quench with saturated NH4Cl. 
 
 In a Scheme 33, benzylmagnesium chloride (13) and 1-(dimethylsulfamoyl)-4-
iodoimidazole (4) do not couple directly, rather undergo exchange (a) preceding the actual cross-
coupling. Additionally, 4 is being consumed by a side-reaction (d) - catalytic reduction to 1-
(dimethylsulfamoyl)imidazole (8). Another source of 8 is the quench of arylgrignard 14 while 
the work-up (e). As with the direct coupling, 1-(dimethylsulfamoyl)-4-imidazolylmagnesium 
halide 14 may form a homocoupling product 17 (c). It is unclear, however, how the benzyl 
homocoupling 18 is formed (c) and whether benzyl iodide (15) is involved. 
 We studied how the nature of a ligand influences the outcome of the reaction. For that we 
selected seven phosphorus ligands having different denticity, electronic and sterical properties 
(Figure 5).  
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Figure 5: Phosphorus ligands for Kumada cross-coupling. 
 
 The results are presented in the Table 5. 
Table 5: Coupling with different ligands. 
Entry Ligand Yield [%]
b
 
16 8 4 17 
1 no ligand 70 21 8 1 
2 L1 73 22 5 0 
3 L2 60 36 3 0 
4 L3 76 20 4 1 
5 L4 61 32 5 1 
6 L5 68 25 5 2 
7 L6 77 18 4 1 
8 L7 19 72 8 2 
aTo a solution of 1-(dimethylsulfamoyl)-4-iodoimidazole (0.050 g, 0.166 mmol), Fe(acac)3 
(0.006 g, 0.017 mmol, 10 mol%) and a ligand (20 mol%) in THF (0.5 ml) at -84 oC 
benzylmagnesium chloride solution (0.3 M in THF, 0.68 ml, 0.200 mmol) was added. Reaction 
was kept at low temperature for 4.5 h and then left in the cooling bath to warm up to room 
temperature overnight. bAccording to GC-MS. 
 
 As can be seen from the Table 5, in most of the cases the ligand has little influence on the 
yield of the cross-coupling. No ligand (Entry 1) gives the yield of the cross-coupling 16 that 
differs from most of other entries by 5-10%. The only exception is the Entry 9 where we used 
bidentate 1,2-bis(diphenylphosphino)ethane. We think it binds to the catalytic species too 
strongly reducing its reactivity, therefore the process almost stops on the Grignard exchange 
(Scheme 30). 
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 We repeated the reaction with no ligand at the conditions that gave us the best result in 
Table 4. The GC-MS yield was 78%, however we had problems with the work-up and isolation. 
We tried three different procedures (Table 6). 
Table 6: Procedures for the work-up and isolation. 
Entry Work-up and isolation Isolated yield [%] 
1 Procedure 1b 5 
2 Procedure 2c 15 
3 Procedure 3d 65 
aTo a solution of 1-(dimethylsulfamoyl)-4-iodoimidazole (0.050 g, 0.166 mmol), Fe(acac)3 
(0.006 g, 0.017 mmol, 10 mol%) in THF at -63 oC benzylmagnesium chloride solution (0.3 M in 
THF, 0.68 ml, 0.200 mmol) was added. Reaction was kept at low temperature for 6 h and left in 
a cooling bath to warm up to room temperature. bThe reaction mixture was diluted with 3 
volumes of 1M HCl, extracted with 4 volumes of Et2O three times. The product was isolated 
using silicagel column chromatography (EtOAc:hexane(1.5:1) + 1.5% NEt3 → EtOAc + 5% 
NEt3). cThe reaction mixture was quenched with 1 volume of saturated aqueous NH4Cl, extracted 
with 2 volumes of Et2O three times. The product was isolated using silicagel column 
chromatography (EtOAc:hexane(1.5:1) + 1.5% NEt3 → EtOAc + 5% NEt3). dThe reaction 
mixture was diluted with 3 volumes of DCM and directly deposited onto a small amount of silica 
followed by evaporation of a solvent. Dry silica with the reaction mixture was then charged on a 
top of a chromatography column. The product was isolated using silicagel column 
chromatography (EtOAc:hexane(1.5:1) + 1.5% NEt3 → EtOAc + 5% NEt3). 
 
 From the Table 6 it can be seen that the aqueous acidic (Entry 1) or neutral (Entry 2) 
quench result in very poor isolated yield, most likely due to good solubility of the cross-coupling 
product 16 in water. Only dilution with DCM and direct deposition onto small amount of silica 
with subsequent flash-chromatography provides the isolated yield of 65%. It is worth pointing 
out that the cross-coupling product strongly interacts with silica and provides high degree of 
tailing even with 1.5% of NEt3 in the eluent. To separate and get all the compound out of the 
column the gradient was used from [EtOAc:hexane(1.5:1) + 1.5% NEt3] to [EtOAc + 5% NEt3]. 
 
4.3.3 Scope 
 We tested the developed procedure with different organomagnesium halides (Scheme 
34).  
 
Scheme 34: Coupling with different Grignard reagents. 
 
The results are presented in a Table 7. 
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Table 7: Scope of the reaction. 
Entry RMgX 
Yield [%]c 
 
8 4 
1 
 
78 19 3 
2 
 
traces >99 0 
3b 
 
5 95 0 
4 
 
traces >99 0 
5 MgBr
 
6 24 70 
6 
MgBr
OCH3
 
9 8 83 
aTo a solution of 1-(dimethylsulfamoyl)-4-iodoimidazole (0.050 g, 0.166 mmol), Fe(acac)3 
(0.006 g, 0.017 mmol, 10 mol%) in THF at -63 oC benzylmagnesium chloride solution (1.2 eqiv) 
was added so the reaction volume reaches 1.2 ml. Reaction was kept at low temperature for 6 h 
and then left in the cooling bath to warm up to room temperature overnight. b1.2 equiv of LiCl 
added. cAccording to GC-MS. 
 
 In a Table 7, the Entry 1 with benzylmagnesium chloride is given for comparison. The 
building block for the structure of naamidine B (Figure 1), p-methoxymagnesium bromide, gave 
only traces of the cross-coupling product (Entry 2). We associate this result with poor solubility 
of p-methoxybenzylmagnesium bromide in THF at -63 oC. Precipitation of crystals from 0.19 M 
solution was already observed at 0 oC and when it was heated up to room temperature and 
injected into the reaction vial, a layer of solid instantaneously formed on the bottom. We 
considered poor solubility as a consequence of high affinity between an oxygen of the methoxy 
group and a magnesium center. Due to this interaction the molecules of a Grignard reagent 
strongly interact with one another and readily form a solid phase. To prevent such a process we  
introduced 1.2 equiv of LiCl into the reaction (Entry 3). We expected it to complexate with both 
oxygen and magnesium centers thus increasing the solubility of p-methoxybenzylmagnesium 
bromide. In this experiment instead of traces we got the cross-coupling product in a yield if 5%. 
Ethylmagnesium bromide (Entry 4) gave only traces of the cross-coupling which is in line with 
the conclusions of Scheiper et al.37 According to the authors, the catalytically active species and 
the mechanism of the reaction depend on the reducing power of a Grignard reagent. 
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Ethylmagnesium bromide is a stronger reductant than benzylmagnesium halides and conditions 
providing the best yield of the cross-coupling may be different for it. Additionally, the coloration 
of the reaction mixture after addition of EtMgBr was yellow as opposed to bloody red with 
benzylgrignards. This may indicate different oxidation state of the iron catalytic species. We 
have also attempted the cross-coupling with arylgrignard reagents (Entries 5 and 6). Both of 
them gave the yield of 6 an 9% correspondingly and the majority of the starting material 4 was 
unreacted, which could be a consequence of too low reaction temperature. 
 Following the procedure by Fuerstner et al.35c, we increased the temperature for the cross-
coupling. Additionally, we tested 1-(dimethylsulfamoyl)-4-chloroimidazole (6) in the reaction 
with phenylmagnesium bromide. 
N
N
X
N
N
N
N
DMAS DMAS DMAS
Fe(acac)3 (5 mol%)
+
8
THF
-30 oC, 10 min
MgBr
+
20
 
Scheme 35: Coupling with phenylmagnesium bromide. 
 
 The results are presented in a Table 8. 
Table 8: Coupling with phenylmagnesium bromide. 
Entry X 
Yield [%]b 
20 8 
 
1 Cl (6) 24 0 76 
2 I (4) 2 98 0 
aTo a solution of 1-(dimethylsulfamoyl)-4-haloidazole (0.166 mmol), Fe(acac)3 (0.003 g, 0.009 
mmol, 5 mol%) in THF (2.75 ml) at -30 oC phenylmagnesium bromide solution (1 M in THF, 
0.39 ml, 0.390 mmol) was added. Reaction was kept at low temperature for 10 min and then 
quenched with saturated aqueous NH4Cl and analyzed with GC-MS. bAccording to GC-MS. 
 
 From the Table 8, chloride 6 gives 24% yield of the cross-coupling (Entry 1) as compared 
to 2% for iodide 4 (Entry 2). Additionally, there is a lot of starting material left, therefore the 
reaction may be optimized. 
 We studied the influence of a halogen in the imidazole core on the outcome of the cross-
coupling with benzylmagnesium chloride (13) (Scheme 36). 
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Scheme 36: Attempt on the cross-coupling with the chloride 4. 
 
 The starting chloride 4 was detected intact in GC-MS which indicates that C-Cl bond in 4 
is too strong at -63 oC for the Grignard exchange or the oxidative addition to take place. 
 We have also attempted bis-benzylation of 1-(dimethylsulfamoyl)-4,5-diiodoimidazole 
(5), however, as with the copper-catalyzed cross-coupling, the reaction stopped on a Grignard 
exchange (Scheme 37). 
 
Scheme 37: Attempt on bis-benzylation. 
 
 No catalytic reduction took place (Scheme 31). When the reaction was quenched with 
D2O, only [M+1] peak of 4 was observed in GC-MS. 
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5 Concluding remarks and future work 
 We have developed a synthetic route to intermediate 21 (R=H). The intermediates 1, 2 
and 4 have been synthesized in the yields comparable to those from the literature.42,43,44 The last 
step towards 21 is a novel iron-catalyzed Kumada cross-coupling. It can be improved to afford 
R=OMe which will lead to a structural fragment of the target naamidine B. The methodology for 
the further benzylation and methylation is in its incipient state and will be developed within our 
research group. The dibenzylated methylimidazole 22 can be then transformed into the 
corresponding azide 23 via lithiation followed by treatment with tosyl azide. The intermediate 23 
can be catalytically reduced to an amine 24 which will give the target molecule naamidine B 
after condensation with TMS-activated derivative of N-methylparabanic acid.15 
 
Scheme 38: Suggested synthesis of naamidine B. The yields from the literature are given in 
parentheses. 
 
 The yield of the procedure for the novel iron-catalyzed Kumada cross-coupling may be 
improved by using longer reaction times and optimizing the work-up. 
 The scope and the functional group tolerance of the new procedure must be tested. It is 
also important to vary the heterocyclic core because it may provide new biologically active 
substances analogous to naamidines.  
 Since the procedure operates at -63 oC, the scope of it is limited by the solubility of a 
Grignard reagent at this temperature. For this reason a coupling with p-methoxybenzyl bromide 
(10) provided poor yield, meanwhile benzylmagnesium chloride (13) worked well. We think that 
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the solubility of the former is decreased due to the presence of an oxygen atom which has high 
affinity to magnesium, thus intensifying intermolecular interactions and facilitating precipitation 
of a Grignard reagent. Therefore, an oxygen atom should be protected with a bulky silyl group 
(Figure 6) which will hinder intermolecular interactions both sterically and electronically 
increasing the solubility. 
 
Figure 6: Silyl-protected benzylmagnesium chloride. R - bulky group. 
 
 It is also important to investigate the influence of a catalyst precursor on the optimal 
conditions and the yield of the cross-coupling. Iron(III) salen complex is interesting in this 
respect since it forms a more stable catalytic species than Fe(acac)3. This fact may allow to run 
the reaction at higher temperature which will also solve the solubility problem, thus expanding 
the scope of a new procedure. 
 A new method for preparing 1-(dimethylsulfamoyl)-4-chloroimidazole (6) was 
discovered. It utilized copper-catalyzed halogen exchange and provides the title compound as a 
single product in an isolated yield of 74%. It may be improved by optimizing the work-up. 
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6 Experimental section 
6.1 General experimental methods 
 All chemicals were purchased from Sigma-Aldrich Norway and used without further 
purification unless otherwise stated. Anhydrous reactions were carried out under inert 
atmosphere of argon or nitrogen gases. Anhydrous CH2Cl2 over 4A-molecular sieves was 
purchased from Sigma-Aldrich Norway. THF was dried in sodium/benzophenone solvent still 
under positive nitrogen pressure and taken for each experiment directly from there. DMF, NMP, 
sulfolane were kept over 4A-molecular sieves. Pyridine was distilled from solid KOH under 
argon, degassed in 6 cycles of the freeze-pump-thaw technique and kept in a dark place over 4A-
molecular sieves. 
 Reaction monitoring was performed by thin-layer chromatography (TLC) on silica gel 
aluminum plates from Sigma-Aldrich Norway (Silica 60A, 40-63 µm with fluorescent indicator 
254 nm). UV lamp (254 nm) was used for detection. Another means of monitoring used was GC-
MS instrument with EI source. GC-MS yields are uncorrected. 
 Cooling of reactions was achieved using liquid nitrogen slush baths made by adding 
liquid nitrogen carefully to a solvent contained in the Dewar flask, with continuous stirring 
(using a glass rod). The coolant should become consistency of ice cream. The solvents used to 
achieve different temperature are given in the Table 9. 
Table 9: Solvents for cooling bath.53 
Temperature 
[oC] Solvent 
-23 CCl4 
-30 PhBr 
-41 CH3CN 
-63 CHCl3 
-84 EtOAc 
  
 Flash column chromatography was performed using silica gel from Merck (Silica gel 60, 
40-63 µm, supplied by Fluka). Elution was performed by mixtures of ethyl acetate and hexane in 
different ratios with 1-5% of NEt3. 
 The 1H (400 MHz) and 13C (100 MHz) NMR spectra were recorded on a Bruker 
Spectrospin DPX-400 MHz spectrometer. Chemical shifts are expressed in parts per million 
(ppm) relative to the signal of the remaining NMR-active nuclei in the deuterated solvent used. 
The coupling constants (J) are quoted in Hz and the multiplicity of the signals in 1H NMR 
spectra was given as singlet (s), doublet (d), doublet of doublet (dd), triplet (t), quartet (q) and 
multiplet (m). 
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 HRMS spectra were recorded using a JEOLAccuTOF JMS T100LC-TOF MS instrument. 
 Infrared spectra were recorded using FTIR spectrometer Nicolet 380. 
 Melting points were measured by Stewart apparatus. 
 
6.2 Ancillary materials and procedures 
 CuCN•2LiCl solution (1M in THF)54: 
 CuCN•2LiCl solution (1M in THF) was prepared by drying a mixture of CuCN (3.59 g, 
40 mmol) and LiCl (3.39 g, 80 mmol) in a Schlenk tube under deep vacuum at 140 oC for 6 h. 
After cooling anhydrous THF (40 ml) was added and a mixture was sonicated at room 
temperature until the salts dissolved to form yellow-green solution. 
 
 LiCl solution (0.5 M in THF)54: 
 LiCl solution (0.5 M in THF) was prepared by drying LiCl (0.85 g, 20 mmol) in a 
Schlenk tube under deep vacuum at 140 oC for 6 h. After cooling anhydrous THF (40 ml) was 
added and a mixture was sonicated at room temperature until the salt dissolved to form clear 
solution. 
 
 Anhydrous CuCl46: 
 CuCl was dissolved in a minimal amount of concentrated hydrochloric acid to form green 
solution which was then carefully diluted with water until precipitation stopped. The solid was 
filtered off on a sinter, washed with a small portion of ether, swiftly dried and partly (10 g) 
transferred into a round-bottom flask with 25 ml of SOCl2. Evolution of HCl and SOCl2 began at 
once, and when bubbling stopped, the slurry was refluxed for 2 h. Then thionyl chloride was 
removed by vacuum distillation into a liquid nitrogen trap. The resulting brownish powder was 
transferred in a vacuum dessicator containing potassium hydroxide and stored for 12 h to get rid 
of remaining SOCl2. 
 
 Titration of Grignard reagents53: 
 Resublimed iodine (ca. 60 mg, weighted accurately) is placed in a dry 10-cm3 round-
bottom flask or small Pyrex test tube fitted with a magnetic stirrer bar and a septum. The system 
is then purged with argon (or nitrogen) and kept under a positive inert gas pressure, using a 
needle adapter from an inert gas line or balloon. Anhydrous lithium chloride (4 cm3 of 0.5 M 
solution in THF) is then added via a syringe). The mixture is stirred until iodine is completely 
dissolved and then cooled to 0 oC using an ice bath. The solution of Grignard reagent is then 
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added dropwise using an accurate 1-cm3 syringe, until the brown colour disappears. At this 
point, the volume of Grignard solution added is noted. The molarity of the solution can be 
calculated using Eq. 1. 
 
 To obtain an accurate titer, it is necessary to carry out this titration at least three times 
and calculate the average of the results obtained. 
 
6.3 Synthetic procedures 
6.3.1 4,5-Diiodo-1H-imidazole (1)42  
 To a solution of imidazole (11.1 g, 0.163 mol) in NaOH (4.0 M, 600 ml) was drop-wise 
added solution of KI (147.2 g, 0.887 mol) and I2 (88.2 g, 0.348 mol) in water (500 ml) over a 
period of 30 minutes. The reaction mixture was stirred for 24h at room temperature and then 
neutralized with acetic acid, resulting in precipitation of product. The mixture was cooled on ice, 
the crystals filtered and finally washed with several portions of ice-water. The product was air-
dried to provide the title compound as chalky powder in a yield of 82% (59.5 g, 13.4 mmol). 
 
1H NMR (DMSO-d6): δ 7.78 (1H, s). 
13C NMR (DMSO-d6): δ 141.7. 
FT-IR (neat) ῦ (cm-1): 620.5 (w), 653.2 (m), 817.0 (m), 917.3 (m), 954.4 (s), 1151.0 (m), 
1178.8 (m), 1270.6 (w), 1284.0 (m), 1422.0 (w), 1454.0 (w), 1548.2 (w), 2548.4 (w). 
M.P. 185.7-186.6 oC. 
 
6.3.2 4-(5)-Iodo-1H-imidazole (2)43 
 4,5-diiodo-1H-imidazole (38.0 g, 85.3 mol) and K2SO3 (186 g, 1.17 mol) were refluxed 
in 30% ethanol (400 ml). After 24h the reaction mixture was cooled to room temperature, 
ethanol removed under reduced pressure and inorganic salts removed by filtration. The resulting 
water phase was saturated with sodium chloride and extracted with diethyl ether (3x300 ml). The 
organic layers were combined and washed with small portions (10 ml) of saturated solution of 
K2SO3 until the yellowish color disappeared. The organic phase was then dried over anhydrous 
Na2SO4, filtered and the solvent evaporated under reduced pressure to provide the title 
compound as a white solid in a yield of 65% (12.1 g, 62.3 mmol).  
 
TLC: Rf=0.47 [EtOAc:Hx(1:1)]. 
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1H-NMR (400 MHz, CDCl3): δ 7.17 (1H, s), 7.62 (1H, s).  
13C NMR (CDCl3): δ 137.2, 123.3. 
FT-IR (neat) ῦ (cm-1): 616.6 (s), 659.7 (m), 758.0 (m), 768.6 (m), 828.5 (m), 906.6 (w), 952.1 
(m), 1066.4 (m), 1163.0 (m), 1213.3 (w), 1286.3 (w), 1429.7 (w), 1537.4 (w). 
M.P. 137.9-138.3 oC. 
 
6.3.3 1-(Dimethylsulfamoyl)-4-iodoimidazole (4)44 
 4-(5)-Iodo-1H-imidazole (15.00 g, 77.33 mmol) was dissolved in THF (150 ml) in a 
round-bottom flask which was then sealed with a septum and flushed with argon. N,N-
Dimethylsulfamoyl chloride (8.72 ml, 81.20 mmol) and 50% aqueous NaOH (6.10 ml, 116.00 
mmol) were added, and the reaction was stirred for 24 h at room temperature. On completion, it 
was diluted with water (75 ml) and EtOAc (150 ml). Organic layer was separated, dried over 
anhydrous Na2SO4 and further diluted with heptane (150 ml). The resulting solution was 
evaporated to white suspension of about one fourth of initial volume and stirred under argon at 
70 oC for 4 h. Then the mixture was cooled down to 0 oC, filtered through sinter and crystals 
were washed with cold hexane (3 x 40 ml). The residual solvent was immediately removed in 
vacuo to give the title compound as white crystalline powder in a yield of 91% (21.20 g, 70.37 
mmol). 
 The title compound is prone to partial oxidation in the air forming insoluble solid, 
therefore it should be kept in a dark place under inert gas. Purification can be achieved by 
dissolving in a minimal volume of CH2Cl2 (only non-oxidized compound dissolves) and filtering 
through a pad of silica with subsequent washing with several volumes of CH2Cl2. 
 
TLC: Rf=0.63 [EtOAc:Hx(1.5:1) + 0.8% NEt3]. 
1H-NMR (CDCl3): δ 2.87 (6H, s), 7.33 (1H, s), 7.76 (1H, s).  
13C NMR (CDCl3): δ 38.3, 84.5, 122.8, 138.0. 
FT-IR (neat) ῦ (cm-1): 532.1 (w), 591.9 (s), 651.2 (w), 725.3 (s), 760.2 (w), 832.5 (m), 921.3 
(m), 958.5 (m), 1001.3 (m), 1052.9 (m), 1066.0 (m), 1141.1 (m), 1152.6 (m), 1167.4 (m), 1212.5 
(w), 1271.9 (w), 1317.7 (w), 1380.4 (m), 1417.2 (w), 1425.1 (w), 1490.3 (w). 
HRMS (ESI): m/z [M+H]+ calculated for C5H9IN3O2S: 301.94601; found: 301.94633. 
M.P. 130.6-133.3 oC. 
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6.3.4 1-(Dimethylsulfamoyl)-4,5-diiodoimidazole (5) 
 4,5-Diiodo-1H-imidazole (4.00 g, 12.50 mmol) was placed in a round-bottom flask which 
was then sealed with a septum and flushed with argon. THF (30 ml) was injected followed by 
N,N-dimethylsulfamoyl chloride (1.48 ml, 13.76 mmol) and 50% aqueous NaOH (1.00 ml, 18.75 
mmol). The mixture was stirred and water was added dropwise until clear solution formed. 
Stirring was continued for 24 h; then the reaction was diluted with water (30 ml) and EtOAc 
(100 ml). The aqueous layer was extracted with EtOAc (2 x 100 ml), and combined organic 
layers were dried over anhydrous Na2SO4. The solvent was removed in vacuo, the residue was 
redissolved in minimal volume of CH2Cl2 and filtered through a layer of silica which was then 
washed with several portions of CH2Cl2. Recrystalization from CH2Cl2-hexane provided the title 
compound as white crystals in a yield of 78% (4.16 g, 9.75 mmol). 
 The title compound is prone to partial oxidation in the air forming insoluble solid, 
therefore it should be kept in a dark place under inert gas. Purification can be achieved by 
dissolving in a minimal volume of CH2Cl2 (only non-oxidized compound dissolves) and filtering 
through a pad of silica with subsequent washing with several volumes of CH2Cl2. 
 
TLC: Rf=0.44 [EtOAc:Hx(1:1.5)]. 
1H-NMR (CDCl3): δ 3.02 (6H, s), 8.07 (1H, s).  
13C NMR (CDCl3): δ 39.0, 102.7, 143.1. 
FT-IR (neat) ῦ (cm-1): 540.8 (m), 577.9 (s), 657.4 (m), 716.6 (m), 822.8 (w), 849.1 (w), 933.6 
(m), 958.6 (m), 1027.3 (m), 1133.3 (m), 1153.3 (w), 1187.2 (w), 1273.1 (w), 1382.8 (w), 1425.5 
(w), 1465.5 (w), 2163.6 (w), 3116.3 (w). 
HRMS (ESI): m/z [M+H]+ calculated for C5H8I2N3O2S: 427.84266; found: 427.84277. 
M.P. 115.0-117.5 oC. 
 
6.3.5 1-(Dimethylsulfamoyl)-4-chloroimidazole (6) 
 An oven-dried vial was equipped with a magnetic stirring bar and charged with 1-
(dimethylsulfamoyl)-4-iodoimidazole (0.050 g, 0.17 mmol) and freshly recrystallized anhydrous 
copper(I) chloride (0.164 g, 1.66 mmol). The vial was then sealed with a septum, flushed with 
argon and filled with anhydrous degassed pyridine (2.0 ml). Once the solvent was added, 
inorganic salt formed lumps which were be broken by sonication. The mixture was stirred at 110 
oC for 24 h. Upon completion, the reaction was diluted with CH2Cl2 (5 ml), poured into saturated 
aqueous NH4Cl containing 30% concentrated NH3 (1 ml) and extracted with CH2Cl2 (3 x 20 ml). 
Combined organic layers were dried over anhydrous Na2SO4 and the solvent evaporated under 
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reduced pressure. The crude product was purified using silicagel column chromatography 
[EtOAc:Hx(3:7) + 3% NEt3] to provide the target product as white crystals in a yield of 74% 
(0.026 g, 0.13 mmol). 
 The title compound is prone to partial oxidation in the air forming insoluble solid, 
therefore it should be kept in a dark place under inert gas. Purification can be achieved by 
dissolving in a minimal volume of CH2Cl2 (only non-oxidized compound dissolves) and filtering 
through a pad of silica with subsequent washing with several volumes of CH2Cl2. 
 
TLC: Rf=0.43 [EtOAc:Hx(1.5:1) + 1% NEt3]. 
1H-NMR (CDCl3): δ 2.83 (6H, s), 7.10 (1H, s), 7.71 (1H, s).  
13C NMR (CDCl3): δ 38.3, 113.6, 132.1, 135.5. 
FT-IR (neat) ῦ (cm-1): 541.1 (m), 599.9 (s), 660.7 (w), 730.7 (m), 755.5 (m), 836.1 (m), 946.5 
(m), 962.6 (m), 1004.4 (m), 1074.1 (m), 1168.3 (m), 1184.0 (m), 1219.6 (w), 1271.7 (w), 1320.0 
(w), 1381.6 (m), 1419.3 (w), 1458.8 (w), 1520.8 (w). 
HRMS (ESI): m/z [M+H]+ calculated for C5H9ClN3O2S: 210.01040; found: 210.01066. 
M.P. 121.2-123.3 oC. 
 
6.3.6 1-(Dimethylsulfamoyl)-4-imidazolylmagnesium bromide (7) 
 An oven-dried vial was equipped with a magnetic stirring bar and charged with 1-
(dimethylsulfamoyl)-4-iodoimidazole (0.100 g, 0.33 mmol). The vial was sealed with a septum, 
flushed with argon, filled with anhydrous THF (2.0 ml) and placed into an ice bath. EtMgBr (3.0 
M solution in ether, 0.11 ml, 0.33 mmol) was added to the solution over a minute. Almost 
immediately the reaction became turbid. According to GC-MS, the Grignard exchange is 
complete in 5 min. 
 For GC-MS monitoring 0.2 ml aliquote was taken from the reaction, quenched with 0.1 
ml of saturated aqueous NH4Cl and diluted with 10 ml of EtOAc. The organic phase was filtered 
through a cotton wool plug prior to GC-MS bottle being charged with it. 
 
6.3.7 Benzylmagnesium chloride (13) 
 An oven-dried vial was equipped with a magnetic stirring bar and charged with 
magnesium turnings (0.36 g, 14.97 mmol). The vial was sealed with a septum, flushed with 
argon and filled with anhydrous THF (20 ml). Then, benzyl chloride (1.00 ml, 7.18 mmol) was 
added and the mixture was sonicated for 5 min at room temperature. The aforementioned 
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manipulations yield ~0.3 M solution of benzylmagnesium chloride in THF. The concentration 
can be ascertained by titration (see the procedure above). 
 
6.3.8 Typical procedure for the copper-catalyzed coupling 
 1-(Dimethylsulfamoyl)-4-benzylidazole. An oven-dried vial was equipped with a 
magnetic stirring bar and charged with 1-(dimethylsulfamoyl)-4-iodoimidazole (0.050 g, 0.166 
mmol). The vial was then sealed with a septum, flushed with argon, filled with anhydrous THF 
(3.0 ml) and stirred until the solid dissolved. Then 1.0 M solution of CuCN•2LiCl (34 µl, 0.033 
mmol) in dry THF was added and the reaction was submerged into a liquid nitrogen/CCl4 slush 
bath (-23 oC). The mixture was stirred for 5 min and benzylmagnesium chloride solution (0.3 M 
in THF, 0.68 ml, 0.200 mmol) was then added. The pale-yellow reaction mixture was stirred at -
23 oC for at least 4h and then left overnight to warm up to r.t. On the next day the reaction was 
poured into saturated aqueous NH4Cl containing 30% concentrated NH3 (0.5 ml) and extracted 
with CH2Cl2 (3 x 15 ml). Combined organic layers were dried over anhydrous Na2SO4 and 
analyzed with GC-MS and 1H NMR. 
 For GC-MS monitoring 0.2 ml aliquote was taken from the reaction, quenched with 0.1 
ml of saturated aqueous NH4Cl containing 30% of concentrated NH3 and diluted with 10 ml of 
EtOAc. The organic phase was filtered through a layer of silica prior to GC-MS bottle being 
charged with it. 
 
6.3.9 Attempted bis-benzylation of 1-(dimethylsulfamoyl)-4,5-diiodoimidazole (5) 
 An oven-dried vial was equipped with a magnetic stirring bar and charged with 1-
(dimethylsulfamoyl)-4,5-diiodoimidazole (0.073 g, 0.17 mmol). The vial was sealed with a 
septum, flushed with argon and filled with anhydrous CH2Cl2. Benzylmagnesium chloride 
solution (0.3 M in THF, 0.68 ml, 0.20 mmol) was then added and reaction mixture was stirred at 
room temperature. In 20 min 1.0 M solution of CuCN•2LiCl (0.20 ml, 0.20 mmol) in dry THF 
was added. The orange reaction solution was stirred at r.t. for 48 h and then poured into saturated 
aqueous NH4Cl containing 30% of concentrated NH3 (1 ml). After stirring for 30 min the 
resulting solid was filtered off and the filtrate extracted with CH2Cl2 (3 x 4 ml). Combined 
organic layers were dried over anhydrous Na2SO4 and analyzed with GC-MS and 1H NMR. 
 For GC-MS monitoring 0.2 ml aliquote was taken from the reaction, quenched with 0.1 
ml of saturated aqueous NH4Cl containing 30% of concentrated NH3 and diluted with 10 ml of 
EtOAc. The organic phase was filtered through a layer of silica prior to GC-MS bottle being 
charged with it. 
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6.3.10 Typical procedure for the direct iron-catalyzed coupling 
 An oven-dried vial was equipped with a magnetic stirring bar and charged with Fe(acac)3 
(0.0117 g, 0.03 mmol, 10 mol%). The vial was sealed with a septum, flushed with argon, filled 
with anhydrous THF (2.0 ml) and stirred until the solids dissolved. Then p-methoxybenzyl 
bromide (48 µl, 0.33 mmol) was injected through the septum. The vial was placed into an ice 
bath and in 5 min suspension of 1-(dimethylsulfamoyl)-4-imidazolylmagnesium bromide (0.33 
mmol in 2 ml THF) was added via a syringe and reaction mixture was stirred at r.t. for 1 h.  
 For GC-MS monitoring 0.2 ml aliquote was taken from the reaction, quenched with 0.1 
ml of saturated aqueous NH4Cl and diluted with 10 ml of EtOAc. It was left in the air for about 
10 min until the solution became yellow. The organic phase was filtered through a layer of silica 
prior to GC-MS bottle being charged with it. 
 
6.3.11 Typical procedure for the inverse iron-catalyzed coupling 
 1-(Dimethylsulfamoyl)-4-benzylimidazole. An oven-dried vial was equipped with a 
magnetic stirring bar and charged with 1-(dimethylsulfamoyl)-4-iodoimidazole (0.050 g, 0.166 
mmol) and Fe(acac)3 (0.006 g, 0.017 mmol, 10 mol%). The vial was then sealed with a septum, 
flushed with argon, filled with anhydrous THF (0.5 ml), stirred until solids dissolved and placed 
into a liquid nitrogen/chloroform slush bath (-63 oC). The mixture was stirred for 5 min and 
benzylmagnesium chloride solution (0.3 M in THF, 0.68 ml, 0.200 mmol) was then added. The 
bloody-red reaction mixture was stirred at -63 oC for at least 6 h and then left overnight to warm 
up to r.t. On the next day the reaction was diluted with DCM (4 ml), deposited onto small 
amount of silica and purified using silicagel column chromatography [EtOAc:Hx(1.5:1) + 1.5% 
NEt3 → EtOAc + 5% NEt3]. The procedure afforded the title product as yellow oil in a yield of 
65% (0.027 g, 0.101 mmol). 
 The title compound is prone to partial oxidation in the air forming insoluble solid, 
therefore it should be kept in a dark place under inert gas. Purification can be achieved by 
dissolving in a minimal volume of CH2Cl2 (only non-oxidized compound dissolves) and filtering 
through a pad of silica with subsequent washing with several volumes of CH2Cl2. 
 For GC-MS monitoring 0.2 ml aliquote was taken from the reaction, quenched with 0.1 
ml of saturated aqueous NH4Cl and diluted with 10 ml of EtOAc. It was left in the air for about 
10 min until the solution became yellow. The organic phase was filtered through a layer of silica 
prior to GC-MS bottle being charged with it. 
 
TLC: Rf=0.29 [EtOAc:Hx(1.5:1) + 0.8% NEt3]. 
 49
1H-NMR (CDCl3): δ 2.83 (6H, s), 3.94 (2H, s), 6.85 (1H, s), 7.28 (5H, m), 7.88 (1H, s). 
13C NMR (CDCl3): δ 34.4, 38.5, 126.9, 128.9, 129.0, 138.2. 
FT-IR (neat) ῦ (cm-1): 564.6 (m), 596.2 (s), 615.5 (m), 673.5 (s), 695.5 (m), 711.4 (s), 726.7 
(m), 757.7 (w), 800.8 (w), 861.9 (w), 904.4 (w), 960.2 (m), 1002.8 (m), 1066.2 (m), 1167.1 (s), 
1191.5 (w), 1217.6 (m), 1248.1 (w), 1272.1 (w), 1379.0 (s), 1455.1 (w), 1495.1 (w), 2342.1 (m), 
2359.8 (m), 2923.8 (w), 3108.3 (w), 3141.8 (w). 
HRMS (ESI): m/z [M+H]+ calculated for C12H16N3O2S: 266.09632; found: 266.09641. 
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